Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

Pfizer PFE underwent analysis by 4 analysts in the last quarter ... While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE – Research Report), Nanobiotix (NBTX – Research ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other ...

Pfizer and Allergan have confirmed that they ... driven by the potential savings they are able to deliver to healthcare systems. The ISPE Singapore Affiliate Conference & Exhibition is one of ...

Undoubtedly the biggest story of the week was the scrapping of the $160 billion merger between Pfizer and Allergan ... says WHO The World Health Organisation (WHO) released a report into worldwide ...

Is now the time to buy Supernus Pharmaceuticals? Access our full analysis of the earnings results here, it’s free. Originally spun off from Pfizer in 2013 as the world's largest pure-play animal ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White ...

In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other ...